We talk to Jiangjiang (Chris) Zhu about his career, emerging technologies and MS-based metabolomics as a focus for his recent work.
In this installment of Robert MacNeill’s (Envigo) column, Robert discusses the instability of drugs within samples and how to balance their instability against absorptive loss.
Over the past 7 years, Bioanalysis Zone have supported and recognized outstanding early-career researchers in the field of bioanalysis. We followed up with all our previous nominees to discover where they are now and discuss the impact of being nominated for the award.
In this ‘Ask the Experts’ feature, the experts discuss the complexity and cost of development and whether biosimilars are more affordable therapeutic options.
In this ‘Ask the Experts’ feature we will be discussing what is required to gain approval for a biosimilar.
In this ‘Ask the Experts’ feature we will be discussing the use of biosimilars with a number of leading experts across the field. The series will explore the role of biosimilars, address the benefits and challenges of creating them and how they have gained momentum within the pharmaceutical industry.
The ability to efficiently and robustly characterise drugs and metabolites during DMPK studies is a vital part of the drug…
Take our survey on emerging technologies: DMPK and bioanalysis of small molecules!
We talk to Gary J. Van Berkel about his career, emerging technologies and immediate drop on demand technology coupled with mass spectrometry as a focus for his recent work.